PBTQ Gains, Lifted by Celgene, Genzyme Friday, October 1, 8:43 AM ET, by Market News Video Staff The PowerShares Global Biotech Portfolio (PBTQ) has a market value of only $3.7 million, but ...
Genzyme Insists $69 Per Share Too Low Friday, October 22, 3:32 PM ET, by Market News Video Staff The Board of Directors for Genzyme Corp. (GENZ) continues to rebuff the hostile takeover efforts ...
AMGN, BIIB Initiated at Sell Thursday, November 4, 12:51 PM ET, by Market News Video Staff Coverage of both Amgen (AMGN) and Biogen Idec (BIIB) was initiated at Goldman Sachs (GS) ...
GENZ Searches for “White Knight” to Trump Sanofi Monday, November 15, 12:13 PM ET, by Market News Video Staff Genzyme (GENZ) shares are trading higher today on media reports that it is trying to ...
GENZ Sells Diagnostics Business for $265M Thursday, November 18, 12:18 PM ET, by Market News Video Staff Genzyme (GENZ) said today it has agreed to sell its diagnostic products business to Sekisui ...
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.